Aleks Engel, Director,
REPAIR Impact Fund, Novo Holdings
What do you see as the biggest challenges facing the AMR space into 2022?
Loss of further talent to other therapeutic areas due to lack of funding
Further bankruptcies that will further scare away investors
If you could wave a magic wand, what would you like to see occur in the coming year to further combat AMR?
The passage of the PASTEUR Act. We absolute need it
What would you like to highlight about your work/your organization for this coming year?
We are working on closing two new investments in Q1
We will open the REPAIR Impact Fund 2022 call for proposals in May
Do you have any predictions for the AMR space in 2022 and beyond? Any calls-to-action you’d like to highlight?
The G7 finance ministers will realize that without reimbursement reform their countries will not get access to new drugs will finally move on subscription models